Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association Between Pharmacy Proximity With Cardiovascular Medication Use and Risk Factor Control in the United States.
Zheutlin AR, Sharareh N, Guadamuz JS, Berchie RO, Derington CG, Jacobs JA, Mondesir FL, Alexander GC, Levitan EB, Safford M, Vos RO, Qato DM, Bress AP. Zheutlin AR, et al. Among authors: jacobs ja. J Am Heart Assoc. 2024 Mar 5;13(5):e031717. doi: 10.1161/JAHA.123.031717. Epub 2024 Feb 23. J Am Heart Assoc. 2024. PMID: 38390820 Free PMC article.
Association Between Self-Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of SPRINT (Systolic Blood Pressure Intervention Trial).
Jacobs JA, Derington CG, Zheutlin AR, King JB, Cohen JB, Bucheit J, Kronish IM, Addo DK, Morisky DE, Greene TH, Bress AP. Jacobs JA, et al. J Am Heart Assoc. 2024 Feb 6;13(3):e031574. doi: 10.1161/JAHA.123.031574. Epub 2024 Jan 19. J Am Heart Assoc. 2024. PMID: 38240275 Free PMC article.
Glucagon-like peptide-1 receptor agonist and sodium-glucose cotransporter 2 inhibitor use among adults with diabetes mellitus by cardiovascular-kidney disease risk: National Health and Nutrition Examination Surveys, 2015-2020.
Jacobs JA, Zheutlin AR, Derington CG, King JB, Pandey A, Bress AP. Jacobs JA, et al. Am J Prev Cardiol. 2023 Nov 27;17:100624. doi: 10.1016/j.ajpc.2023.100624. eCollection 2024 Mar. Am J Prev Cardiol. 2023. PMID: 38125205 Free PMC article.
New Users of Angiotensin II Receptor Blocker-Versus Angiotensin-Converting Enzyme Inhibitor-Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD-BP and SPRINT.
King JB, Berchie RO, Derington CG, Marcum ZA, Scharfstein DO, Greene TH, Herrick JS, Jacobs JA, Zheutlin AR, Bress AP, Cohen JB. King JB, et al. Among authors: jacobs ja. J Am Heart Assoc. 2023 Sep 5;12(17):e030311. doi: 10.1161/JAHA.123.030311. Epub 2023 Aug 30. J Am Heart Assoc. 2023. PMID: 37646208 Free PMC article.
Single-Pill Combination Product Availability of the Antihypertensive Regimens Used for Intensive Systolic Blood Pressure Treatment in the Systolic Blood Pressure Intervention Trial.
King JB, Derington CG, Herrick JS, Jacobs JA, Zheutlin AR, Conroy MB, Cushman WC, Bress AP. King JB, et al. Among authors: jacobs ja. Hypertension. 2023 Aug;80(8):1749-1758. doi: 10.1161/HYPERTENSIONAHA.123.21132. Epub 2023 Jun 8. Hypertension. 2023. PMID: 37288570 Clinical Trial.
Evidence for Age Bias Contributing to Therapeutic Inertia in Blood Pressure Management: A Secondary Analysis of SPRINT.
Zheutlin AR, Addo DK, Jacobs JA, Derington CG, Herrick JS, Greene T, Stulberg EL, Berlowitz DR, Williamson JD, Pajewski NM, Supiano MA, Bress AP. Zheutlin AR, et al. Among authors: jacobs ja. Hypertension. 2023 Jul;80(7):1484-1493. doi: 10.1161/HYPERTENSIONAHA.123.21323. Epub 2023 May 11. Hypertension. 2023. PMID: 37165900 Clinical Trial.
171 results